Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Johnson & Johnson Is Using Stock to Buy Synthes
NY Times, NY
Wednesday, May 11, 2011 - 8:46am
tags:
JNJ, Synthes, M&A
Waiting for MannKind's Pot of Gold
Motley Fool
Wednesday, May 11, 2011 - 8:45am
tags:
MannKind, inhaled insulin, diabetes
Allergan’s Botox: Beyond the Vanity Market
Barron's
Tuesday, May 10, 2011 - 5:45pm
tags:
Allergan, Botox
Why The Judge Acquitted The Former Glaxo Lawyer
Pharmalot
Tuesday, May 10, 2011 - 5:44pm
tags:
GSK, off-label
FDA grants faster review to Bayer's regorafenib
Yahoo/AP
Tuesday, May 10, 2011 - 5:44pm
tags:
Bayer, FDA, regorafenib, gastrointestinal cancer
Pfizer's Multibillion-Dollar Blockbuster Set to Grow
Motley Fool
Tuesday, May 10, 2011 - 5:42pm
tags:
Pfizer, Prevnar 13, pneumococcal disease, vaccines
FDA Proposes Biosimilar User Fees
Pharmalot
Tuesday, May 10, 2011 - 12:08pm
tags:
user fees, FDA, biosimilars
NPS Pharma: Positive Gattex Data Presented
TheStreet.com
Tuesday, May 10, 2011 - 12:06pm
tags:
NPS Pharmaceuticals, Gattex, short bowel syndrome
Why BioSante Expects a Positive Review of Drug for Female Sexual Disorder
Seeking Alpha
Tuesday, May 10, 2011 - 12:05pm
tags:
BioSante, female sexual dysfunction, LibiGel
CytRx: A Cancer Drug Developer Evidently Undervalued
Seeking Alpha
Tuesday, May 10, 2011 - 12:04pm
tags:
CytRx, cancer
Pharma CEOs lost in the executive-pay shuffle
Fierce Pharma
Tuesday, May 10, 2011 - 10:43am
tags:
Pharma CEOs, executive pay
Former Glaxo Lawyers Asks Judge To Dismiss Case
Pharmalot
Tuesday, May 10, 2011 - 10:42am
tags:
GSK, off-label, FDA, Wellbutrin SR
Why Is Sequenom Up 20%?
Motley Fool
Tuesday, May 10, 2011 - 10:29am
tags:
Sequenom
MannKind: Afrezza Delayed Again
TheStreet.com
Tuesday, May 10, 2011 - 10:28am
tags:
MannKind, Afrezza, inhaled insulin, diabetes
Inspire Pharma 1Q loss grows on restructuring cost
Yahoo/AP
Tuesday, May 10, 2011 - 10:13am
tags:
earnings, Inspire
Avanir posts bigger 2Q loss on drug launch costs
Yahoo/AP
Tuesday, May 10, 2011 - 10:13am
tags:
Avanir, earnings
Abbott’s Humira Meets Primary Endpoints in Phase III Study
Bloomberg
Tuesday, May 10, 2011 - 10:12am
tags:
Humira, Abbott Laboratories, ulcerative colitis
Aurobindo Pharma Mulls Spinning Off Units
WSJ Online
Tuesday, May 10, 2011 - 10:10am
tags:
Aurobindo
Sanofi Seeks to Expand in Animal Health, CEO Says, FT Reports
Bloomberg
Tuesday, May 10, 2011 - 10:10am
tags:
animal health, Sanofi, Chris Viehbacher
Johnson & Johnson's Remicade meets key goal in pediatric ulcerative colitis study
Yahoo/AP
Monday, May 9, 2011 - 6:48pm
tags:
JNJ, ulcerative colitis, Remicade

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.